Affimed

YTD

ALL

Why Robinhood?

You can watch Affimed and buy or sell other stocks, ETFs, and their options commission-free!

About AFMD

Affimed NV is a clinical-stage immuno-oncology company, which engages in the discovery and development of cancer immunotherapies. The company’s proprietary ROCK platform enables a tumor-targeted approach to recognize and kill a range of hematologic and solid tumors, enabling a broad pipeline of wholly-owned and partnered single agent and combination therapy programs.

CEO

Shawn M. Leland, PharmD

CEOShawn M. Leland, PharmD

Employees

—

Employees—

Headquarters

Mannheim, Baden Wuerttemberg

HeadquartersMannheim, Baden Wuerttemberg

Founded

2000

Founded2000

Employees

—

Employees—

AFMD Key Statistics

Market cap

3.00K

Market cap3.00K

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

3.94K

Average volume3.94K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$0.237

52 Week high$0.237

52 Week low

—

52 Week low—

Stock Snapshot

The current Affimed(AFMD) stock price is $5.91, with a market capitalization of 3K.

On 2026-05-16, Affimed(AFMD) shares started trading at —, with intraday highs of — and lows of —.

Trading activity shows a volume of 0, compared to an average daily volume of 3.94K.

People also own

Based on the portfolios of people who own AFMD. This list is generated using Robinhood data, and it’s not a recommendation.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.